Clinical and Translational Allergy

Editor in Chief

Prof. Dr. Med. Oliver Pfaar

We are delighted to announce that Oliver Pfaar has been appointed as the Editor-in-Chief of CLT2. As an international key-opinion leader in allergology, rhinology, and clinical immunology he heads the Section of Rhinology and Allergy of the Department of Otorhinolaryngology at Philipps University Marburg, Germany. He is Vice-President of the European Academy of Allergy and Clinical Immunology (EAACI). His work manly focuses on allergen immunotherapy (AIT), respiratory allergies, and biologic treatments for chronic rhinosinusitis with nasal polyps (CRSwNP). He is actively involved in clinical research and international guideline development (h-index 73, SCOPUS June 2025)

Deputy Editor

Prof. María M Escribese, PhD

Dr. Escribese is Vice Dean of Research and Director of the Institute of Molecular Applied Medicine at the School of Medicine in San Pablo CEU University. She has been Principal investigator of several translational research projects and is a leading member of the National Network of inflammatory Diseases.

Currently Dr. Escribese is a member of the European Academy of Allergy and Clinical Immunology as Member at large and of the Coalition for Advancing Research Assessment, CoARA.

Her research interest is focus in the use of system biology to identify novel biomarkers for allergic patients stratification. Her contributions to science and education have earned her prestigious honors, including the 2022 EAACI PhARF Award and the Ángel Herrera Award for Research Excellence.